Table 2 Statistics of SMAD4 mRNA levels in glioma
From: Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients
| Â | No. of cases | SMAD mean (SD) | P |
|---|---|---|---|
Tissue type | Â | Â | Â |
Control | 42 | 2.096 (0.338) | <0.01 |
Glioma | 252 | 0.861 (0.223) | Â |
WHO grade | Â | Â | Â |
I | 53 | 1.517 (0.097) | <0.001 |
II | 60 | 1.205 (0.136) | Â |
III | 62 | 0.615 (0.412) | Â |
IV | 77 | 0.339 (0.036) | Â |
KPS | Â | Â | Â |
<80 | 135 | 0.372 (0.113) | <0.001 |
≥80 | 117 | 1.425 (0.375) |  |